Hyoprox 50 DS Dry Syrup contains Cefpodoxime Proxetil 50mg/5ml, a third-generation cephalosporin antibiotic with broad-spectrum activity against various gram-positive and gram-negative bacteria. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, and pharyngitis caused by susceptible organisms. Upon oral administration, Cefpodoxime Proxetil is rapidly absorbed and converted to its active form, cefpodoxime, which inhibits bacterial cell wall synthesis, leading to cell lysis and death. Hyoprox 50 DS Dry Syrup is particularly useful in pediatric patients due to its palatable formulation and ease of administration. The dosage and duration of therapy should be determined based on the severity of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of bacterial resistance. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur and warrant immediate discontinuation and medical attention. Caution is advised in patients with a history of cephalosporin or penicillin allergy. Hyoprox 50 DS Dry Syrup should be stored in a cool, dry place and reconstituted as per instructions before use.